QQQ   294.47 (+1.41%)
AAPL   115.17 (+1.16%)
MSFT   213.86 (+1.78%)
FB   276.92 (+3.16%)
GOOGL   1,763.90 (+2.10%)
AMZN   3,118.06 (+0.63%)
TSLA   555.38 (+6.43%)
NVDA   518.31 (-1.39%)
BABA   279.96 (+3.65%)
CGC   26.97 (+9.10%)
GE   10.45 (+3.77%)
MU   63.95 (-0.36%)
AMD   85.07 (-0.28%)
T   29.23 (+2.13%)
NIO   53.51 (-3.38%)
F   9.45 (+6.66%)
ACB   9.23 (+28.55%)
NFLX   482.88 (+1.31%)
GILD   60.25 (+0.60%)
BA   218.49 (+3.29%)
DIS   151.49 (+3.77%)
QQQ   294.47 (+1.41%)
AAPL   115.17 (+1.16%)
MSFT   213.86 (+1.78%)
FB   276.92 (+3.16%)
GOOGL   1,763.90 (+2.10%)
AMZN   3,118.06 (+0.63%)
TSLA   555.38 (+6.43%)
NVDA   518.31 (-1.39%)
BABA   279.96 (+3.65%)
CGC   26.97 (+9.10%)
GE   10.45 (+3.77%)
MU   63.95 (-0.36%)
AMD   85.07 (-0.28%)
T   29.23 (+2.13%)
NIO   53.51 (-3.38%)
F   9.45 (+6.66%)
ACB   9.23 (+28.55%)
NFLX   482.88 (+1.31%)
GILD   60.25 (+0.60%)
BA   218.49 (+3.29%)
DIS   151.49 (+3.77%)
QQQ   294.47 (+1.41%)
AAPL   115.17 (+1.16%)
MSFT   213.86 (+1.78%)
FB   276.92 (+3.16%)
GOOGL   1,763.90 (+2.10%)
AMZN   3,118.06 (+0.63%)
TSLA   555.38 (+6.43%)
NVDA   518.31 (-1.39%)
BABA   279.96 (+3.65%)
CGC   26.97 (+9.10%)
GE   10.45 (+3.77%)
MU   63.95 (-0.36%)
AMD   85.07 (-0.28%)
T   29.23 (+2.13%)
NIO   53.51 (-3.38%)
F   9.45 (+6.66%)
ACB   9.23 (+28.55%)
NFLX   482.88 (+1.31%)
GILD   60.25 (+0.60%)
BA   218.49 (+3.29%)
DIS   151.49 (+3.77%)
QQQ   294.47 (+1.41%)
AAPL   115.17 (+1.16%)
MSFT   213.86 (+1.78%)
FB   276.92 (+3.16%)
GOOGL   1,763.90 (+2.10%)
AMZN   3,118.06 (+0.63%)
TSLA   555.38 (+6.43%)
NVDA   518.31 (-1.39%)
BABA   279.96 (+3.65%)
CGC   26.97 (+9.10%)
GE   10.45 (+3.77%)
MU   63.95 (-0.36%)
AMD   85.07 (-0.28%)
T   29.23 (+2.13%)
NIO   53.51 (-3.38%)
F   9.45 (+6.66%)
ACB   9.23 (+28.55%)
NFLX   482.88 (+1.31%)
GILD   60.25 (+0.60%)
BA   218.49 (+3.29%)
DIS   151.49 (+3.77%)
Log in
ASX:MDR

MedAdvisor Limited (MDR.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
A$0.53
MA: A$0.52▼
A$0.53
52-Week Range N/A
Volume719,064 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MedAdvisor Limited, together with its subsidiaries, develops and delivers software for personal medication management in Australia. It develops and deploys the MedAdvisor, a medication and adherence platform that connects health professionals with patients using mobile and web technologies. MedAdvisor Limited was incorporated in 2010 and is headquartered in Camberwell, Australia.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.52 out of 5 stars


Industry, Sector and Symbol

Stock Exchange ASX
Industry Health Information Services
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolASX:MDR
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.medadvisor.com.au
Phone61 3 9095 3036
EmployeesN/A

Debt

Debt-to-Equity Ratio8.35
Current Ratio4.84
Quick Ratio4.71

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$9.60 million
Price / Sales0.00
Cash FlowN/A
Price / Cash Flow7.95
Book ValueA$0.07 per share
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableOptionable

Receive MDR News and Ratings via Email

Sign-up to receive the latest news and ratings for MDR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











MedAdvisor Limited (MDR.AX) (ASX:MDR) Frequently Asked Questions

What stocks does MarketBeat like better than MedAdvisor Limited (MDR.AX)?

Wall Street analysts have given MedAdvisor Limited (MDR.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but MedAdvisor Limited (MDR.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of MedAdvisor Limited (MDR.AX)'s key competitors?

Some companies that are related to MedAdvisor Limited (MDR.AX) include 1st Group Limited (1ST.AX) (1ST), Alcidion Group Limited (ALC.AX) (ALC), Cann American (CNNA), CannaOne Technologies (CNONF), CB2 Insights (CBIIF), CloudMD Software & Services (DOCRF), CloudMD Software & Services Inc. (DOC.V) (DOC), Cogstate Limited (CGS.AX) (CGS), CompuMed (CMPD), Corum Group Limited (COO.AX) (COO), EGF Theramed Health (EVAHF), Emyria Limited (EMD.AX) (EMD), eWellness Healthcare (EWLL), Global Health Limited (GLH.AX) (GLH) and ICS Global Limited (ICS.AX) (ICS).
View all competitors.

Who are MedAdvisor Limited (MDR.AX)'s key executives?

MedAdvisor Limited (MDR.AX)'s management team includes the following people:
  • Mr. Robert Read BComm(Mgt), BA(Psych), GAICD, MD, CEO & Exec. Director
  • Mr. Joshua Swinnerton MEI, GradCert Eng., BE, BCS(Hons)., Founder, Chief Product Officer & Exec. Director
  • Mr. Simon Glover, Chief Financial Officer
  • Mr. Carlo Campiciano, Company Sec.
  • Mr. Craig Schnuriger, Interim Chief Technology Officer
  • Ms. Naomi Lawrie, Company Sec. & Gen. Counsel
  • Jennifer Duraisingam, Corp. Communications Mang.
  • Mr. Theo Antonopoulos, Head of Sales & Marketing
  • Ms. Ruba El-Afifi, Exec. Gen. Mang. of People & Culture
  • Mr. Jamal Butt, Head of Commercial

What is MedAdvisor Limited (MDR.AX)'s stock symbol?

MedAdvisor Limited (MDR.AX) trades on the ASX under the ticker symbol "MDR."

How big of a company is MedAdvisor Limited (MDR.AX)?

MedAdvisor Limited (MDR.AX) has a market capitalization of $0.00 and generates $9.60 million in revenue each year.

What is MedAdvisor Limited (MDR.AX)'s official website?

The official website for MedAdvisor Limited (MDR.AX) is www.medadvisor.com.au.

How can I contact MedAdvisor Limited (MDR.AX)?

The company can be reached via phone at 61 3 9095 3036.

This page was last updated on 11/24/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.